|
|
Volumn 12, Issue 1, 2001, Pages 95-97
|
|
Medical-legal implications of anticoagulation
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICOAGULANT AGENT;
CLEMASTINE FUMARATE;
GLIBENCLAMIDE;
TRANYLCYPROMINE;
VITAMIN K GROUP;
WARFARIN;
ANTICOAGULATION;
BLEEDING;
COMPUTER ANALYSIS;
COMPUTER PROGRAM;
CONFERENCE PAPER;
COST;
DRUG LABELING;
DRUG LEGISLATION;
EXPERT WITNESS;
FATALITY;
HUMAN;
HYPOTHESIS;
INTERNATIONAL STANDARD UNIT;
LAW;
LAW SUIT;
MALPRACTICE;
MEDICAL DECISION MAKING;
MEDICAL ETHICS;
MEDICAL LIABILITY;
MEDICAL RECORD;
MEDICOLEGAL ASPECT;
NEGLIGENCE;
PATIENT COMPLIANCE;
PHARMACIST;
PRIORITY JOURNAL;
PRIVACY;
RISK MANAGEMENT;
STROKE;
ANTICOAGULANTS;
HUMANS;
JURISPRUDENCE;
MALPRACTICE;
MEDICAL ERRORS;
RISK MANAGEMENT;
THROMBOEMBOLISM;
UNITED STATES;
|
|
EID: 0035179993
PISSN: 09295305
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1012750830446 Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (11)
|
